(Q41094672)

English

DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant

scientific article published on August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

0 references

cancer cell line

1 reference

based on heuristic

inferred from title

author name string

N Joto

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

M Ishii

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

M Minami

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

H Kuga

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

I Mitsui

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

A Tohgo

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

680-686

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

describes a project that uses

0 references

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Characterization of camptothecin-resistant chinese hamster lung cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Establishment and characterization of human gastric and colonic xenograft lines resistant to CPT-11 (a new derivative of camptothecin).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970807%2972%3A4%3C680%3A%3AAID-IJC21%3E3.0.CO%3B2-E

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19970807)72:4<680::AID-IJC21>3.0.CO;2-E

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41094672&oldid=2093449746"